• Follow Us:
  • About
    • Team
    • Board of Directors
    • Annual Reports
    • Job Board
    • Events
      • Breakthru
      • R3
  • Venture Capital
    • Venture Capital: What We Do
    • Startup Investment Fund
    • Venture Capital Fund
    • Innovation Voucher Fund
    • Venture Capital Investment Process
    • Portfolio Companies
  • Applied Research
    • Applied Research: What We Do
    • Technology Advancement
      • Emerging Projects Fund
      • Lab-to-Market Fund
      • Equipment Fund
      • Social Innovation Research Fund
      • COVID-19 Research Fund
      • Strategic Opportunities Fund
      • NBIF Mitacs Accelerate Internships
    • Student Development
      • Graduate Scholarships
      • Research Assistantships Initiative
      • New Brunswick Priority Occupation Student Support Fund (NBPOSS)
    • Research Professional Support
      • Start-up Awards
      • Research Professionals Initiative
      • NB Innovation Research Chair
    • Applied Research Process
    • Researcher Portfolio
    • Star Mentors
  • Early Stage Commercialization Fund
  • News
    • Blog
    • In The News
  • ENEN
    • FRFR

what-we-do

  • what-we-do
  • January 8, 2020
  • Comments : 0

what-we-do

  • Share This Article :

Search

Categories

  • In the News
  • Venture Capital
  • Applied Research
  • Breakthru
  • NBIF News
  • R3
  • Innovation Insights
  • Uncategorized

Archives

CONTACT US

40 Crowther Lane
Suite 110
Fredericton, NB E3C 0J1

Toll Free: 1.877.554.6668
Telephone: 506.452.2884
Fax: 506.452.2886

info@nbif.ca

VENTURE CAPITAL

  • Startup Investment Fund
  • Venture Capital Fund
  • Innovation Voucher Fund
  • Venture Capital Investment Process
  • Portfolio Companies

APPLIED RESEARCH

  • Applied Research: What We Do
  • Technology Advancement
  • Student Development
  • Research Professional Support
  • Applied Research Process
  • Researcher Portfolio

Signup for our newsletter

Sign up
© 2003-2020 New Brunswick Innovation Foundation. All rights reserved.
An announcement from NBIF regarding COVID-19.
Read here